There are still safety trials to be completed. Data has to be collected, checked, double-checked, and then peer-reviewed. And we still need to find out whether it is the most effective of the various candidates currently in development or whether there is something even better just around the corner. But the Pfizer vaccine has already proved something beyond any reasonable doubt.
Already a subscriber? Log in
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Comments
Black Friday sale
Subscribe today and get 10 weeks of The Spectator Australia for just $1
SUBSCRIBEAlready a subscriber? Log in